DSpace JSPUI


DSpace preserves and enables easy and open access to all types of digital content including text, images, moving images, mpegs and data sets

Learn More

Please use this identifier to cite or link to this item: http://repositorio.insp.mx:8080/jspui/handle/20.500.12096/8229
Full metadata record
DC FieldValueLanguage
dc.coverage.spatialnacional
dc.creatorAGUILAR ESPINOSA, ANDREA VIRGINIA
dc.date.accessioned2023-05-25T14:21:30Z-
dc.date.available2023-05-25T14:21:30Z-
dc.date.issued2020
dc.identifier.urisicabi.insp.mx:2020-None
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297796/pdf/41598_2020_Article_65665.pdf
dc.identifier.urihttps://www.doi.org/ 10.1038/s41598-020-65665-y
dc.identifier.urihttp://repositorio.insp.mx:8080/jspui/handle/20.500.12096/8229-
dc.description.abstractAbstract In breast cancer, high levels of homeobox protein Hox-B13 (HOXB13) have been associated with disease progression of ER-positive breast cancer patients and resistance to tamoxifen treatment. Since HOXB13 p.G84E is a prostate cancer risk allele, we evaluated the association between HOXB13 germline mutations and breast cancer risk in a previous study consisting of 3,270 familial non-BRCA1/2 breast cancer cases and 2,327 controls from the Netherlands. Although both recurrent HOXB13 mutations p.G84E and p.R217C were not associated with breast cancer risk, the risk estimation for p.R217C was not very precise. To provide more conclusive evidence regarding the role of HOXB13 in breast cancer susceptibility, we here evaluated the association between HOXB13 mutations and increased breast cancer risk within 81 studies of the international Breast Cancer Association Consortium containing 68,521 invasive breast cancer patients and 54,865 controls. Both HOXB13 p.G84E and p.R217C did not associate with the development of breast cancer in European women, neither in the overall analysis (OR = 1.035, 95% CI = 0.859-1.246, P = 0.718 and OR = 0.798, 95% CI = 0.482-1.322, P = 0.381 respectively), nor in specific high-risk subgroups or breast cancer subtypes. Thus, although involved in breast cancer progression, HOXB13 is not a material breast cancer susceptibility gene.
dc.formatpdf
dc.languagespa
dc.publisherESPM INSP
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0
dc.subjectBreast Neoplasms , genetics, Female Genetic Predisposition to Disease , genetics Genotyping Techniques Germ-Line Mutation , genetics, Homeodomain Proteins , genetics, Humans Middle Aged Risk Factors
dc.titleGermline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk
dc.typeinfo:eu-repo/semantics/article
dc.subject.ctiinfo:eu-repo/classification/cti/3
dc.creator.curpcurp/AUEA911115MDFGSN00;AGUILAR ESPINOSA, ANDREA VIRGINIA
dc.creator.orcidorcid/0000-0001-6713-4351;Gago, Manuela
dc.creator.orcidorcid/0000-0001-7065-1237;Michailidou, Kyriaki
dc.creator.orcidorcid/0000-0001-6951-6855;Peterlongo, Paolo
dc.creator.orcidorcid/0000-0001-6906-3390;Simard, Jacques
dc.creator.orcidorcid/0000-0003-4052-6392;Torres-Mejia, Gabriela
Appears in Collections:Artículos

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.